Phase I Trial of Oral PX-866

Clinical trial NCT00726583 · COMPLETED

Trial details

NCT number: NCT00726583
Sponsor: Cascadian Therapeutics Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2008-06-01
Primary completion: 2011-09-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.